MA5-31959
antibody from Invitrogen Antibodies
Targeting: LRP1
A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunocytochemistry [3]
- Immunohistochemistry [5]
- Flow cytometry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-31959 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- LRP1 Recombinant Rabbit Monoclonal Antibody (SA0290)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Antibody clone number
- SA0290
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB).
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
Shi X, Wang Z, Ren W, Chen L, Xu C, Li M, Fan S, Xu Y, Chen M, Zheng F, Zhang W, Zhou X, Zhang Y, Qiu S, Wu L, Zhou P, Lv X, Cui T, Qiao Y, Zhao H, Guo W, Chen W, Li S, Zhong W, Lin J, Yang S
Signal transduction and targeted therapy 2022 Jun 10;7(1):175
Signal transduction and targeted therapy 2022 Jun 10;7(1):175
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
Shimizu-Albergine M, Basu D, Kanter JE, Kramer F, Kothari V, Barnhart S, Thornock C, Mullick AE, Clouet-Foraison N, Vaisar T, Heinecke JW, Hegele RA, Goldberg IJ, Bornfeldt KE
The Journal of clinical investigation 2021 Nov 15;131(22)
The Journal of clinical investigation 2021 Nov 15;131(22)
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of LRP1 in MCF-7 cells using a LRP1 Monoclonal antibody (Product # MA5-31959) as seen in green. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of LRP1 in HUVEC cells using a LRP1 Monoclonal antibody (Product # MA5-31959) as seen in green. Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of LRP1 in Hela cells using a LRP1 Monoclonal antibody (Product # MA5-31959) as seen in green. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of LRP1 of paraffin-embedded Human lung tissue using a LRP1 Monoclonal antibody (Product #MA5-31959). Counter stained with hematoxylin.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of LRP1 of paraffin-embedded Human liver tissue using a LRP1 Monoclonal antibody (Product #MA5-31959). Counter stained with hematoxylin.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of LRP1 in frozen mouse hippocampus. Blocked in 3% BSA for 30 minutes at room temperature, washed with PBS. Incubation was done with monoclonal LRP1 antibody (Product # MA5-31959) at a dilution of 1:100 (at 4°C), followed by Alexa Fluor 488 Goat Anti-Rabbit IgG H&L (1:200) and DAPI.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of LRP1 of paraffin-embedded Mouse liver tissue using a LRP1 Monoclonal antibody (Product #MA5-31959). Counter stained with hematoxylin.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of LRP1 of paraffin-embedded Mouse brain tissue using a LRP1 Monoclonal antibody (Product #MA5-31959). Counter stained with hematoxylin.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow Cytometric analysis of LRP1 in Hela cells using a LRP1 Monoclonal Antibody (Product # MA5-31959) at a dilution of 1:50, as seen in blue compared with an unlabelled control (cells without incubation with primary antibody; red). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 3 LRP1 is responsible for the endocytosis of IETP2. a - d Microscopy images showing the competing endocytosis of IETP2-Cy5.5 and Lix-FITC by HEI-OC1 cells. The endocytosis of IETP2-Cy5.5 was partially reduced by Lix-FITC. e - f Quantitative analysis of the fluorescence intensity in a - d . e Quantitative data showing the percentages of IETP2-Cy5.5-positive cells. f Quantitative data showing the mean intensity of IETP2-Cy5.5 in cells. g RT-PCR showing the knockdown (KD) efficiency of Lrp1 with two different gRNAs. h Western blot showing the expression of LRP1 after LRP1 knockdown with two different gRNAs. i , j Immunofluorescence images showing the expression of LRP1 in WT and LRP1-KD HEI-OC1 cells. k , l Microscopy images showing the endocytosis of IETP2 in WT or LRP1-KD HIE-OC1 cells. Greatly reduced endocytosis of IETP2 in LRP1-KD HEI-OC1 cells was observed. m Quantitative analysis of the images in k , l . n Flow cytometry showing the reduced endocytosis of IETP2 in LRP1-KD HEI-OC1 cells. Error bars represent the mean +- SD. N = 5 for e , f , m . N = 3 for g . * p < 0.05, *** p < 0.001. Scale bars: 20 um